Evidence map›Paper›PMID 35386656›Full record

ReviewFrontiers in allergy2022

Allergenic Properties and Molecular Characteristics of PR-1 Proteins.

Andrea Wangorsch, Stephan Scheurer, Miguel Blanca, Natalia Blanca-Lopez, María Luisa Somoza, Laura Martín-Pedraza

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. LtGAPR1 Is a Novel Secreted Effector fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Andrea WangorschMolecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.
Stephan ScheurerMolecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.
Miguel BlancaFoundation for Biomedical Research and Innovation, Hospital Universitario Infanta Leonor, Madrid, Spain.
Natalia Blanca-LopezAllergy Service, Hospital Universitario Infanta Leonor, Madrid, Spain.
María Luisa SomozaAllergy Service, Hospital Universitario Infanta Leonor, Madrid, Spain.
Laura Martín-PedrazaFoundation for Biomedical Research and Innovation, Hospital Universitario Infanta Leonor, Madrid, Spain.
Hospital Universitario Infanta Leonor · ESPaul Ehrlich Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only a small fraction of proteins in plants and animals are classified as allergens. The allergenic properties are frequently attributed to certain functional characteristics of the proteins, such as a role in the plant defense against biotic and abiotic stress, to achieve the systematic acquired resistance. In line with this, eight members out of 17 functional pathogenesis-related (PR) protein families have been characterized as allergens. The present review summarizes the molecular features and allergenic significance of allergens of the PR-1 family. Not many allergens have been identified as belonging to this protein family, with most of them having a pollen origin, like mugwort or Bermuda grass. Molecular and structural features of allergenic PR-1 proteins are discussed and attributed to their IgE-reactive properties, clinical manifestation, and cross-reactivity among different foods and inhalants.

Indexed as

allergenallergy diagnosisoccupational allergypathogenesis-related protein-1PR-1

Identifiers

PMID35386656
PMCPMC8974740
OpenAlexW4210918440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.